As the potential of biosimilars continues to be explored by the medical community, robust real-world evidence is becoming more important in guiding informed decision-making. This article summarised the current real-world evidence relating to biosimilar use across breast and lung cancer.
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/07/Wearable-Devices-for-Vital-Sign-Monitoring-in-Haematology-and-Oncology-Web-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/07/Laterality-Bias-in-Mammogram-Screening-Web-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/04/Onc-Aparna-Parikh-Interview-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2024/03/TN-1-1-940x564.png)